Our response to new survey by University College London reporting that a fifth of people are unlikely to get vaccinated against COVID-19.
NHS Digital has released the annual report on NHS Immunisation Statistics, England, 2019–20 today. In response, the British Society for Immunology has released the following statement.
BSI response to news that the AstraZeneca-Oxford University coronavirus vaccine trial has been paused to investigate an unexplained illness in one participant.
New national immunology consortium to tackle COVID-19
British Society for Immunology response to new study on new-onset type 1 diabetes in children during COVID-19
British Society for Immunology response to the creation of a new National Institute for Health Protection
British Society for Immunology briefing note highlighting that urgent research into the long-term immunological health consequences of COVID-19 is crucial to prevent placing an additional burden on the NHS in the future.
BSI statement on extension of self-isolation period following COVID-19 symptoms from seven to ten days
BSI response to results of phase 1/2 trial of a vaccine against SARS-CoV-2 by Oxford University
BSI response to new research on COVID-19 immune response.
BSI response to the first in human clinical trials of a new vaccine against COVID-19 from Imperial College London
Today, world leaders have come together at Gavi’s donor pledging conference, the Global Vaccine Summit, which aimed to mobilise at least $7.4 billion towards Gavi’s next strategic cycle (2021-25). Gavi has received $8.8 billion in contributions which surpasses that goal and will protect the next generation through vaccination. In response, the British Society for Immunology has released the following statement.
BSI response to approval of an antibody test against COVID-19 by Public Health England
Our statement on 40 years since smallpox was eradicated.